APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Assay Development

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Assay Development Market Outlook and Growth Opportunities 2026

16 January 2026202 pages

Choose your research edition.

Industry ResearchCustom Assay Development Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Assay Development Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Custom Assay Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Assay Development Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Assay Development Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Custom Assay Development market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Assay Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Assay Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Assay Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Assay Development market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Assay Development market include 2BScientific, PerkinElmer, Eurofins Discovery, Thermo Fisher Scientific, Creative Biolabs, PlexBio, Gyros Protein Technologies, Mission Bio and Sygnature Discovery, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Assay Development market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Assay Development and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Assay Development revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Assay Development market.

Custom Assay Development Segment by Company

2BScientific

PerkinElmer

Eurofins Discovery

Thermo Fisher Scientific

Creative Biolabs

PlexBio

Gyros Protein Technologies

Mission Bio

Sygnature Discovery

AssayGate

Charles River Laboratories

Promega Corporation

ProteoGenix

R&D Systems

Luminex

Eremid Genomic Services

INDIGO Biosciences

Cellomatics Biosciences

Camtech

SynVivo

Custom Assay Development Segment by Type

Assay Development

Assay Optimization

Assay Conversion

New Analyte Development

Custom Coupling

Custom Conjugation

Sample Testing

Other

Custom Assay Development Segment by Application

Medicine

Biology

Environment

Academic

Others

Custom Assay Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Assay Development status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Assay Development key companies, revenue, market share, and recent developments.

3. To split the Custom Assay Development breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Assay Development market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Assay Development significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Assay Development competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Assay Development industry.

Chapter 3: Detailed analysis of Custom Assay Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Assay Development in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Assay Development in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Assay Development Industry Trends Table 2. Custom Assay Development Industry Drivers Table 3. Custom Assay Development Industry Opportunities and Challenges Table 4. Custom Assay Development Industry Restraints Table 5. Global Custom Assay Development Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Assay Development Revenue Share by Company (2021-2026) Table 7. Global Custom Assay Development Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Assay Development Key Company Manufacturing Base & Headquarters Table 9. Global Custom Assay Development Company, Product Type & Application Table 10. Global Custom Assay Development Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Assay Development by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Assay Development Table 15. Significant Companies of Assay Optimization Table 16. Significant Companies of Assay Conversion Table 17. Significant Companies of New Analyte Development Table 18. Significant Companies of Custom Coupling Table 19. Significant Companies of Custom Conjugation Table 20. Significant Companies of Sample Testing Table 21. Significant Companies of Other Table 22. Global Custom Assay Development Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Custom Assay Development Sales Value by Type (2021-2026) & (US$ Million) Table 24. Global Custom Assay Development Sales Value by Type (2027-2032) & (US$ Million) Table 25. Global Custom Assay Development Sales Value Share by Type (2021-2026) Table 26. Global Custom Assay Development Sales Value Share by Type (2027-2032) Table 27. Significant Companies of Medicine Table 28. Significant Companies of Biology Table 29. Significant Companies of Environment Table 30. Significant Companies of Academic Table 31. Significant Companies of Others Table 32. Global Custom Assay Development Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Custom Assay Development Sales Value by Application (2021-2026) & (US$ Million) Table 34. Global Custom Assay Development Sales Value by Application (2027-2032) & (US$ Million) Table 35. Global Custom Assay Development Sales Value Share by Application (2021-2026) Table 36. Global Custom Assay Development Sales Value Share by Application (2027-2032) Table 37. Global Custom Assay Development Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Custom Assay Development Sales Value by Region (2021-2026) & (US$ Million) Table 39. Global Custom Assay Development Sales Value Share by Region (2021-2026) Table 40. Global Custom Assay Development Sales Value by Region (2027-2032) & (US$ Million) Table 41. Global Custom Assay Development Sales Value Share by Region (2027-2032) Table 42. Global Custom Assay Development Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Custom Assay Development Sales Value by Country (2021-2026) & (US$ Million) Table 44. Global Custom Assay Development Sales Value Market Share by Country (2021-2026) Table 45. Global Custom Assay Development Sales Value by Country (2027-2032) & (US$ Million) Table 46. Global Custom Assay Development Sales Value Market Share by Country (2027-2032) Table 47. 2BScientific Company Information Table 48. 2BScientific Business Overview Table 49. 2BScientific Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. 2BScientific Custom Assay Development Product Portfolio Table 51. 2BScientific Recent Development Table 52. PerkinElmer Company Information Table 53. PerkinElmer Business Overview Table 54. PerkinElmer Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. PerkinElmer Custom Assay Development Product Portfolio Table 56. PerkinElmer Recent Development Table 57. Eurofins Discovery Company Information Table 58. Eurofins Discovery Business Overview Table 59. Eurofins Discovery Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Eurofins Discovery Custom Assay Development Product Portfolio Table 61. Eurofins Discovery Recent Development Table 62. Thermo Fisher Scientific Company Information Table 63. Thermo Fisher Scientific Business Overview Table 64. Thermo Fisher Scientific Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Thermo Fisher Scientific Custom Assay Development Product Portfolio Table 66. Thermo Fisher Scientific Recent Development Table 67. Creative Biolabs Company Information Table 68. Creative Biolabs Business Overview Table 69. Creative Biolabs Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Creative Biolabs Custom Assay Development Product Portfolio Table 71. Creative Biolabs Recent Development Table 72. PlexBio Company Information Table 73. PlexBio Business Overview Table 74. PlexBio Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. PlexBio Custom Assay Development Product Portfolio Table 76. PlexBio Recent Development Table 77. Gyros Protein Technologies Company Information Table 78. Gyros Protein Technologies Business Overview Table 79. Gyros Protein Technologies Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Gyros Protein Technologies Custom Assay Development Product Portfolio Table 81. Gyros Protein Technologies Recent Development Table 82. Mission Bio Company Information Table 83. Mission Bio Business Overview Table 84. Mission Bio Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mission Bio Custom Assay Development Product Portfolio Table 86. Mission Bio Recent Development Table 87. Sygnature Discovery Company Information Table 88. Sygnature Discovery Business Overview Table 89. Sygnature Discovery Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sygnature Discovery Custom Assay Development Product Portfolio Table 91. Sygnature Discovery Recent Development Table 92. AssayGate Company Information Table 93. AssayGate Business Overview Table 94. AssayGate Custom Assay Development Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. AssayGate Custom Assay Development Product Portfolio Table 96. AssayGate Recent Development Table 97. Charles River Laboratories Company Information Table 98. Charles River Laboratories Business Overview Table 99. Charles River Laboratories Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Charles River Laboratories Custom Assay Development Product Portfolio Table 101. Charles River Laboratories Recent Development Table 102. Promega Corporation Company Information Table 103. Promega Corporation Business Overview Table 104. Promega Corporation Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Promega Corporation Custom Assay Development Product Portfolio Table 106. Promega Corporation Recent Development Table 107. ProteoGenix Company Information Table 108. ProteoGenix Business Overview Table 109. ProteoGenix Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. ProteoGenix Custom Assay Development Product Portfolio Table 111. ProteoGenix Recent Development Table 112. R&D Systems Company Information Table 113. R&D Systems Business Overview Table 114. R&D Systems Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. R&D Systems Custom Assay Development Product Portfolio Table 116. R&D Systems Recent Development Table 117. Luminex Company Information Table 118. Luminex Business Overview Table 119. Luminex Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Luminex Custom Assay Development Product Portfolio Table 121. Luminex Recent Development Table 122. Eremid Genomic Services Company Information Table 123. Eremid Genomic Services Business Overview Table 124. Eremid Genomic Services Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Eremid Genomic Services Custom Assay Development Product Portfolio Table 126. Eremid Genomic Services Recent Development Table 127. INDIGO Biosciences Company Information Table 128. INDIGO Biosciences Business Overview Table 129. INDIGO Biosciences Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. INDIGO Biosciences Custom Assay Development Product Portfolio Table 131. INDIGO Biosciences Recent Development Table 132. Cellomatics Biosciences Company Information Table 133. Cellomatics Biosciences Business Overview Table 134. Cellomatics Biosciences Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Cellomatics Biosciences Custom Assay Development Product Portfolio Table 136. Cellomatics Biosciences Recent Development Table 137. Camtech Company Information Table 138. Camtech Business Overview Table 139. Camtech Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Camtech Custom Assay Development Product Portfolio Table 141. Camtech Recent Development Table 142. SynVivo Company Information Table 143. SynVivo Business Overview Table 144. SynVivo Custom Assay Development Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. SynVivo Custom Assay Development Product Portfolio Table 146. SynVivo Recent Development Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Custom Assay Development Product Image Figure 2. Global Custom Assay Development Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Assay Development Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Assay Development Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Assay Development Image Figure 8. Assay Optimization Image Figure 9. Assay Conversion Image Figure 10. New Analyte Development Image Figure 11. Custom Coupling Image Figure 12. Custom Conjugation Image Figure 13. Sample Testing Image Figure 14. Other Image Figure 15. Global Custom Assay Development Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Custom Assay Development Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Custom Assay Development Sales Value Share by Type (2021-2032) Figure 18. Medicine Image Figure 19. Biology Image Figure 20. Environment Image Figure 21. Academic Image Figure 22. Others Image Figure 23. Global Custom Assay Development Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Custom Assay Development Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Custom Assay Development Sales Value Share by Application (2021-2032) Figure 26. Global Custom Assay Development Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global Custom Assay Development Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America Custom Assay Development Sales Value (2021-2032) & (US$ Million) Figure 29. North America Custom Assay Development Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Europe Custom Assay Development Sales Value (2021-2032) & (US$ Million) Figure 31. Europe Custom Assay Development Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Asia-Pacific Custom Assay Development Sales Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Custom Assay Development Sales Value Share by Country (%), 2025 VS 2032 Figure 34. South America Custom Assay Development Sales Value (2021-2032) & (US$ Million) Figure 35. South America Custom Assay Development Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Middle East & Africa Custom Assay Development Sales Value (2021-2032) & (US$ Million) Figure 37. Middle East & Africa Custom Assay Development Sales Value Share by Country (%), 2025 VS 2032 Figure 38. USA Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. USA Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. USA Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Canada Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Canada Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Canada Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Mexico Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Mexico Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Mexico Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Germany Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Germany Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Germany Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. France Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. France Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. France Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. U.K. Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. U.K. Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. U.K. Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Italy Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Italy Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Italy Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Spain Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Spain Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Spain Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Russia Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Russia Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Russia Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Netherlands Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Netherlands Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Netherlands Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Nordic Countries Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Nordic Countries Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Nordic Countries Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. China Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. China Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. China Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Japan Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Japan Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Japan Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. South Korea Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. South Korea Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. South Korea Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. India Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. India Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. India Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Australia Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Australia Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Australia Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Southeast Asia Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Southeast Asia Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Southeast Asia Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Brazil Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Brazil Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Brazil Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Argentina Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Argentina Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Argentina Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Chile Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Chile Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Chile Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Colombia Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Colombia Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Colombia Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Peru Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Peru Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Peru Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Saudi Arabia Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Israel Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Israel Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Israel Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. UAE Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. UAE Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. UAE Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Turkey Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Turkey Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Turkey Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Iran Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Iran Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Iran Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Egypt Custom Assay Development Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Egypt Custom Assay Development Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Egypt Custom Assay Development Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Years Considered Figure 123. Research Process Figure 124. Key Executives Interviewed

Scope & coverage.

Types
  • Assay Development
  • Assay Optimization
  • Assay Conversion
  • New Analyte Development
  • Custom Coupling
  • Custom Conjugation
  • Sample Testing
  • Other
Applications
  • Medicine
  • Biology
  • Environment
  • Academic
  • Others
Companies covered
  • 2BScientific
  • PerkinElmer
  • Eurofins Discovery
  • Thermo Fisher Scientific
  • Creative Biolabs
  • PlexBio
  • Gyros Protein Technologies
  • Mission Bio
  • Sygnature Discovery
  • AssayGate
  • Charles River Laboratories
  • Promega Corporation
  • ProteoGenix
  • R&D Systems
  • Luminex
  • Eremid Genomic Services
  • INDIGO Biosciences
  • Cellomatics Biosciences
  • Camtech
  • SynVivo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Assay Development Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Assay Development Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Assay Development Market Dynamics
  1. 2.1 Custom Assay Development Industry Trends
  2. 2.2 Custom Assay Development Industry Drivers
  3. 2.3 Custom Assay Development Industry Opportunities and Challenges
  4. 2.4 Custom Assay Development Industry Restraints
3 Custom Assay Development Market by Company
  1. 3.1 Global Custom Assay Development Company Revenue Ranking in 2025
  2. 3.2 Global Custom Assay Development Revenue by Company (2021-2026)
  3. 3.3 Global Custom Assay Development Company Ranking (2024-2026)
  4. 3.4 Global Custom Assay Development Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Assay Development Company Product Type and Application
  6. 3.6 Global Custom Assay Development Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Assay Development Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Assay Development Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Assay Development Market by Type
  1. 4.1 Custom Assay Development Type Introduction
  2. 4.1.1 Assay Development
  3. 4.1.2 Assay Optimization
  4. 4.1.3 Assay Conversion
  5. 4.1.4 New Analyte Development
  6. 4.1.5 Custom Coupling
  7. 4.1.6 Custom Conjugation
  8. 4.1.7 Sample Testing
  9. 4.1.8 Other
  10. 4.2 Global Custom Assay Development Sales Value by Type
  11. 4.2.1 Global Custom Assay Development Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Custom Assay Development Sales Value by Type (2021-2032)
  13. 4.2.3 Global Custom Assay Development Sales Value Share by Type (2021-2032)
5 Custom Assay Development Market by Application
  1. 5.1 Custom Assay Development Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Biology
  4. 5.1.3 Environment
  5. 5.1.4 Academic
  6. 5.1.5 Others
  7. 5.2 Global Custom Assay Development Sales Value by Application
  8. 5.2.1 Global Custom Assay Development Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Custom Assay Development Sales Value by Application (2021-2032)
  10. 5.2.3 Global Custom Assay Development Sales Value Share by Application (2021-2032)
6 Custom Assay Development Regional Value Analysis
  1. 6.1 Global Custom Assay Development Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Assay Development Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Assay Development Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Assay Development Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Assay Development Sales Value (2021-2032)
  7. 6.3.2 North America Custom Assay Development Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Assay Development Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Assay Development Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Assay Development Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Assay Development Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Assay Development Sales Value (2021-2032)
  16. 6.6.2 South America Custom Assay Development Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Assay Development Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Assay Development Sales Value Share by Country, 2025 VS 2032
7 Custom Assay Development Country-level Value Analysis
  1. 7.1 Global Custom Assay Development Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Assay Development Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Assay Development Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Assay Development Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Assay Development Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Assay Development Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Assay Development Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Assay Development Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Assay Development Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Assay Development Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Assay Development Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Assay Development Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Assay Development Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Assay Development Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Assay Development Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Assay Development Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Assay Development Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Assay Development Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Assay Development Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Assay Development Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Assay Development Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Assay Development Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Assay Development Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Assay Development Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Assay Development Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Assay Development Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Assay Development Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Assay Development Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Assay Development Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Assay Development Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Assay Development Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Assay Development Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Assay Development Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Assay Development Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Assay Development Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 2BScientific
  2. 8.1.1 2BScientific Company Information
  3. 8.1.2 2BScientific Business Overview
  4. 8.1.3 2BScientific Custom Assay Development Revenue and Gross Margin (2021-2026)
  5. 8.1.4 2BScientific Custom Assay Development Product Portfolio
  6. 8.1.5 2BScientific Recent Developments
  7. 8.2 PerkinElmer
  8. 8.2.1 PerkinElmer Company Information
  9. 8.2.2 PerkinElmer Business Overview
  10. 8.2.3 PerkinElmer Custom Assay Development Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer Custom Assay Development Product Portfolio
  12. 8.2.5 PerkinElmer Recent Developments
  13. 8.3 Eurofins Discovery
  14. 8.3.1 Eurofins Discovery Company Information
  15. 8.3.2 Eurofins Discovery Business Overview
  16. 8.3.3 Eurofins Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Discovery Custom Assay Development Product Portfolio
  18. 8.3.5 Eurofins Discovery Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific Custom Assay Development Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Custom Assay Development Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 Creative Biolabs
  26. 8.5.1 Creative Biolabs Company Information
  27. 8.5.2 Creative Biolabs Business Overview
  28. 8.5.3 Creative Biolabs Custom Assay Development Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biolabs Custom Assay Development Product Portfolio
  30. 8.5.5 Creative Biolabs Recent Developments
  31. 8.6 PlexBio
  32. 8.6.1 PlexBio Company Information
  33. 8.6.2 PlexBio Business Overview
  34. 8.6.3 PlexBio Custom Assay Development Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PlexBio Custom Assay Development Product Portfolio
  36. 8.6.5 PlexBio Recent Developments
  37. 8.7 Gyros Protein Technologies
  38. 8.7.1 Gyros Protein Technologies Company Information
  39. 8.7.2 Gyros Protein Technologies Business Overview
  40. 8.7.3 Gyros Protein Technologies Custom Assay Development Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gyros Protein Technologies Custom Assay Development Product Portfolio
  42. 8.7.5 Gyros Protein Technologies Recent Developments
  43. 8.8 Mission Bio
  44. 8.8.1 Mission Bio Company Information
  45. 8.8.2 Mission Bio Business Overview
  46. 8.8.3 Mission Bio Custom Assay Development Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mission Bio Custom Assay Development Product Portfolio
  48. 8.8.5 Mission Bio Recent Developments
  49. 8.9 Sygnature Discovery
  50. 8.9.1 Sygnature Discovery Company Information
  51. 8.9.2 Sygnature Discovery Business Overview
  52. 8.9.3 Sygnature Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sygnature Discovery Custom Assay Development Product Portfolio
  54. 8.9.5 Sygnature Discovery Recent Developments
  55. 8.10 AssayGate
  56. 8.10.1 AssayGate Company Information
  57. 8.10.2 AssayGate Business Overview
  58. 8.10.3 AssayGate Custom Assay Development Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AssayGate Custom Assay Development Product Portfolio
  60. 8.10.5 AssayGate Recent Developments
  61. 8.11 Charles River Laboratories
  62. 8.11.1 Charles River Laboratories Company Information
  63. 8.11.2 Charles River Laboratories Business Overview
  64. 8.11.3 Charles River Laboratories Custom Assay Development Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Charles River Laboratories Custom Assay Development Product Portfolio
  66. 8.11.5 Charles River Laboratories Recent Developments
  67. 8.12 Promega Corporation
  68. 8.12.1 Promega Corporation Company Information
  69. 8.12.2 Promega Corporation Business Overview
  70. 8.12.3 Promega Corporation Custom Assay Development Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Promega Corporation Custom Assay Development Product Portfolio
  72. 8.12.5 Promega Corporation Recent Developments
  73. 8.13 ProteoGenix
  74. 8.13.1 ProteoGenix Company Information
  75. 8.13.2 ProteoGenix Business Overview
  76. 8.13.3 ProteoGenix Custom Assay Development Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ProteoGenix Custom Assay Development Product Portfolio
  78. 8.13.5 ProteoGenix Recent Developments
  79. 8.14 R&D Systems
  80. 8.14.1 R&D Systems Company Information
  81. 8.14.2 R&D Systems Business Overview
  82. 8.14.3 R&D Systems Custom Assay Development Revenue and Gross Margin (2021-2026)
  83. 8.14.4 R&D Systems Custom Assay Development Product Portfolio
  84. 8.14.5 R&D Systems Recent Developments
  85. 8.15 Luminex
  86. 8.15.1 Luminex Company Information
  87. 8.15.2 Luminex Business Overview
  88. 8.15.3 Luminex Custom Assay Development Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Luminex Custom Assay Development Product Portfolio
  90. 8.15.5 Luminex Recent Developments
  91. 8.16 Eremid Genomic Services
  92. 8.16.1 Eremid Genomic Services Company Information
  93. 8.16.2 Eremid Genomic Services Business Overview
  94. 8.16.3 Eremid Genomic Services Custom Assay Development Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Eremid Genomic Services Custom Assay Development Product Portfolio
  96. 8.16.5 Eremid Genomic Services Recent Developments
  97. 8.17 INDIGO Biosciences
  98. 8.17.1 INDIGO Biosciences Company Information
  99. 8.17.2 INDIGO Biosciences Business Overview
  100. 8.17.3 INDIGO Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
  101. 8.17.4 INDIGO Biosciences Custom Assay Development Product Portfolio
  102. 8.17.5 INDIGO Biosciences Recent Developments
  103. 8.18 Cellomatics Biosciences
  104. 8.18.1 Cellomatics Biosciences Company Information
  105. 8.18.2 Cellomatics Biosciences Business Overview
  106. 8.18.3 Cellomatics Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cellomatics Biosciences Custom Assay Development Product Portfolio
  108. 8.18.5 Cellomatics Biosciences Recent Developments
  109. 8.19 Camtech
  110. 8.19.1 Camtech Company Information
  111. 8.19.2 Camtech Business Overview
  112. 8.19.3 Camtech Custom Assay Development Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Camtech Custom Assay Development Product Portfolio
  114. 8.19.5 Camtech Recent Developments
  115. 8.20 SynVivo
  116. 8.20.1 SynVivo Company Information
  117. 8.20.2 SynVivo Business Overview
  118. 8.20.3 SynVivo Custom Assay Development Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SynVivo Custom Assay Development Product Portfolio
  120. 8.20.5 SynVivo Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst